Cargando…
Nanomaterials for Modulating the Aggregation of β-Amyloid Peptides
The aberrant aggregation of amyloid-β (Aβ) peptides in the brain has been recognized as the major hallmark of Alzheimer’s disease (AD). Thus, the inhibition and dissociation of Aβ aggregation are believed to be effective therapeutic strategiesforthe prevention and treatment of AD. When integrated wi...
Autores principales: | Huang, Yaliang, Chang, Yong, Liu, Lin, Wang, Jianxiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305396/ https://www.ncbi.nlm.nih.gov/pubmed/34299575 http://dx.doi.org/10.3390/molecules26144301 |
Ejemplares similares
-
Advanced nanomaterials for modulating Alzheimer's related amyloid aggregation
por: Shao, Xu, et al.
Publicado: (2022) -
In Situ Assembly of Nanomaterials and Molecules for the Signal Enhancement of Electrochemical Biosensors
por: Chang, Yong, et al.
Publicado: (2021) -
TMPyP Inhibits Amyloid-β Aggregation
and Alleviates Amyloid-Induced Cytotoxicity
por: Fan, Yujuan, et al.
Publicado: (2017) -
Modulation of β-amyloid aggregation by graphene quantum dots
por: Liu, Changliang, et al.
Publicado: (2019) -
Key Residue
for Aggregation of Amyloid-β
Peptides
por: Itoh, Satoru G., et al.
Publicado: (2022)